Compare FDC LTD. with Torrent Pharma - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

FDC LTD. vs TORRENT PHARMA - Comparison Results

TORRENT PHARMA 
   Change

Torrent Pharmaceuticals Ltd. is the flagship company of the Torrent Group set up in 1959. Based in Ahmedabad, it was promoted by Mr U.N. Mehta initially as Trinity Laboratories Ltd. and was later renamed to its current name. The company derives its r... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    FDC LTD. TORRENT PHARMA FDC LTD./
TORRENT PHARMA
 
P/E (TTM) x 17.2 58.8 29.2% View Chart
P/BV x 2.3 6.2 37.4% View Chart
Dividend Yield % 0.0 0.8 -  

Financials

 FDC LTD.   TORRENT PHARMA
EQUITY SHARE DATA
    FDC LTD.
Mar-18
TORRENT PHARMA
Mar-18
FDC LTD./
TORRENT PHARMA
5-Yr Chart
Click to enlarge
High Rs3191,550 20.6%   
Low Rs1641,144 14.3%   
Sales per share (Unadj.) Rs61.6354.7 17.4%  
Earnings per share (Unadj.) Rs9.940.1 24.8%  
Cash flow per share (Unadj.) Rs12.064.2 18.6%  
Dividends per share (Unadj.) Rs014.00 0.0%  
Dividend yield (eoy) %01.0 0.0%  
Book value per share (Unadj.) Rs73.2273.1 26.8%  
Shares outstanding (eoy) m174.40169.22 103.1%   
Bonus/Rights/Conversions BB--  
Price / Sales ratio x3.93.8 103.2%   
Avg P/E ratio x24.333.6 72.2%  
P/CF ratio (eoy) x20.221.0 96.3%  
Price / Book Value ratio x3.34.9 66.9%  
Dividend payout %034.9 0.0%   
Avg Mkt Cap Rs m42,118227,897 18.5%   
No. of employees `0005.514.7 37.6%   
Total wages/salary Rs m2,16711,353 19.1%   
Avg. sales/employee Rs Th1,943.74,083.0 47.6%   
Avg. wages/employee Rs Th391.7772.3 50.7%   
Avg. net profit/employee Rs Th313.7461.3 68.0%   
INCOME DATA
Net Sales Rs m10,75160,021 17.9%  
Other income Rs m5102,988 17.1%   
Total revenues Rs m11,26063,009 17.9%   
Gross profit Rs m2,26713,493 16.8%  
Depreciation Rs m3514,086 8.6%   
Interest Rs m143,085 0.5%   
Profit before tax Rs m2,4119,310 25.9%   
Minority Interest Rs m-50-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m6712,529 26.5%   
Profit after tax Rs m1,7356,781 25.6%  
Gross profit margin %21.122.5 93.8%  
Effective tax rate %27.827.2 102.5%   
Net profit margin %16.111.3 142.8%  
BALANCE SHEET DATA
Current assets Rs m7,21352,623 13.7%   
Current liabilities Rs m2,10452,022 4.0%   
Net working cap to sales %47.51.0 4,741.8%  
Current ratio x3.41.0 338.9%  
Inventory Days Days54120 45.6%  
Debtors Days Days2876 36.4%  
Net fixed assets Rs m6,86585,016 8.1%   
Share capital Rs m175846 20.7%   
"Free" reserves Rs m12,58645,376 27.7%   
Net worth Rs m12,76146,222 27.6%   
Long term debt Rs m641,115 0.0%   
Total assets Rs m15,041142,432 10.6%  
Interest coverage x173.24.0 4,311.1%   
Debt to equity ratio x00.9 0.1%  
Sales to assets ratio x0.70.4 169.6%   
Return on assets %11.66.9 167.9%  
Return on equity %13.614.7 92.7%  
Return on capital %19.014.2 133.6%  
Exports to sales %12.30-   
Imports to sales %00-   
Exports (fob) Rs m1,327NA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m1,88914,580 13.0%   
Fx outflow Rs m03,600 0.0%   
Net fx Rs m1,88910,980 17.2%   
CASH FLOW
From Operations Rs m1,4988,942 16.8%  
From Investments Rs m201-47,070 -0.4%  
From Financial Activity Rs m-1,69434,174 -5.0%  
Net Cashflow Rs m10-3,655 -0.3%  

Share Holding

Indian Promoters % 68.9 71.5 96.4%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 4.7 7.0 67.0%  
FIIs % 7.5 12.6 59.5%  
ADR/GDR % 0.0 0.0 -  
Free float % 19.0 8.8 215.9%  
Shareholders   23,730 26,511 89.5%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare FDC LTD. With:   JUBILANT LIFE SCIENCES  DR. DATSONS LABS  CADILA HEALTHCARE  NOVARTIS  PANACEA BIOTECH  

Compare FDC LTD. With:   MYLAN (US)  ADCOCK INGRAM (S. Africa)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Slips Over 300 Points; Axis Bank & Tech Mahindra Top Losers(12:30 pm)

Share markets in India have extended early losses and are presently trading deep in the red. Barring consumer durables sector, all sectoral indices are trading in red with stocks in the telecom sector.

Related Views on News

FDC LTD. Announces Quarterly Results (1QFY20); Net Profit Up 2.4% (Quarterly Result Update)

Aug 6, 2019 | Updated on Aug 6, 2019

For the quarter ended June 2019, FDC LTD. has posted a net profit of Rs 523 m (up 2.4% YoY). Sales on the other hand came in at Rs 3 bn (up 17.9% YoY). Read on for a complete analysis of FDC LTD.'s quarterly results.

TORRENT PHARMA Announces Quarterly Results (1QFY20); Net Profit Up 32.5% (Quarterly Result Update)

Jul 25, 2019 | Updated on Jul 25, 2019

For the quarter ended June 2019, TORRENT PHARMA has posted a net profit of Rs 2 bn (up 32.5% YoY). Sales on the other hand came in at Rs 20 bn (up 8.0% YoY). Read on for a complete analysis of TORRENT PHARMA's quarterly results.

FDC LTD. Announces Quarterly Results (4QFY19); Net Profit Up 6.8% (Quarterly Result Update)

May 30, 2019 | Updated on May 30, 2019

For the quarter ended March 2019, FDC LTD. has posted a net profit of Rs 337 m (up 6.8% YoY). Sales on the other hand came in at Rs 3 bn (down 0.6% YoY). Read on for a complete analysis of FDC LTD.'s quarterly results.

TORRENT PHARMA Announces Quarterly Results (4QFY19); Net Profit Down 166.7% (Quarterly Result Update)

May 22, 2019 | Updated on May 22, 2019

For the quarter ended March 2019, TORRENT PHARMA has posted a net profit of Rs 2 bn (down 166.7% YoY). Sales on the other hand came in at Rs 19 bn (up 7.8% YoY). Read on for a complete analysis of TORRENT PHARMA's quarterly results.

FDC LTD. 2017-18 Annual Report Analysis (Annual Result Update)

Mar 28, 2019 | Updated on Mar 28, 2019

Here's an analysis of the annual report of FDC LTD. for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of FDC LTD.. Also includes updates on the valuation of FDC LTD..

More Views on News

Most Popular

Buying these Eight Stocks is Like Owning Your Own Business(Profit Hunter)

Sep 5, 2019

Everyone dreams of owning a business. Here is your chance.

7 Stocks to Buy in the Market Today(The 5 Minute Wrapup)

Sep 5, 2019

The stock market had a four-year bull run starting September 2013. Are we seeing a similar pattern now?

Don't Buy Lakshmi Vilas Bank...Buy this Private Sector Bank with 74% Upside(The 5 Minute Wrapup)

Sep 4, 2019

Lakshmi Vilas Bank is in a vicious cycle. The stock is already down 57% in 2019. Despite this, the retail investors increased their holding.

Buy these 7 Stocks if You Believe in India(The 5 Minute Wrapup)

Sep 12, 2019

News headlines predict gloom and doom for India these days. You should ignore them.

A Recession Proof Stock You Can Bet On(Profit Hunter)

Sep 10, 2019

Usually, the typical horizon period for my smallcap recommendations is 3 to 5 years. But if you ask me, this could be one business that you could own and pass on to future generations.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2019
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

FDC LTD. SHARE PRICE


Sep 17, 2019 01:55 PM

TRACK FDC LTD.

  • Track your investment in FDC LTD. with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

FDC LTD. - SUN PHARMA COMPARISON

COMPARE FDC LTD. WITH

MARKET STATS